Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy

Lucile Capuron; Alain Ravaud; N. Gualde; Eugène Bosmans; Robert Dantzer; Michael Maes; Pierre J. Neveu

doi:10.1016/s0306-4530(01)00030-0

Back

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy

Article 2001 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy

Lucile Capuron, Alain Ravaud, P.J. Neveu, Andrew H. Miller, Michael Maes, Robert Dantzer

Article2000

Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms

Michael Maes, Ai-hua Lin, Willem Ombelet, Karolien Stevens, Günter Kenis, Raf De Jongh, John Cox, Eugène Bosmans

Article2001

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

Michael Maes, Lucile Capuron, Alain Ravaud, Norbert Gualde, Eugene Bosmans, Belinda Egyed, Robert Dantzer, Pierre J. Neveu

Article2021

Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.

Evangelos Eleutherakis Papaiakovou, Efstathios Kastritis, Flora Zagouri, Dimitra Grapsa, Ioannis Ntanassis-Stathopoulos, Dimitra Stefanou, George Evangelou, Ilias Kotteas, Meletios A Dimopoulos, Konstantinos Syrigos

Article2010

Photodynamic therapy for cancer and activation of immune response

Paweł Mróz, Ying‐Ying Huang, Michael R Hamblin